Articles

ABBV....CELG

Sanofi’s PD-1 inhibitor starts EU review for skin cancer

Inventiva and AbbVie extend agreement for drug discovery

AbbVie and Eisai obtain additional approval for Humira

keppel corp

Navigant Research Report Shows Intelligent Building Solutions Make Hospital Facilities More Efficient, Productive, and Sustainable | Business Wire

AZ signs up for access to Compugen’s pipeline

PRODWAYS

argenx to present complete data from the Phase 2 clinical trial of efgartigimod (ARGX-113) in myasthenia gravis at the American Academy of Neurology Annual Meeting

Bicycle Therapeutics to Present New BT1718 Data in the 'New Drugs on the Horizon' Session at the 2018 American Association for Cancer Research Meeting | Business Wire

Biotech Stocks Facing FDA Decision In April